ADVM Adverum Biotechnologies: Prakiraan wutah bathi kanggo taun ngarep

Lambang korporat lan logo Adverum Biotechnologies (ADVM)

The projected growth in earnings per share for the next fiscal year demonstrates the potential of Adverum Biotechnologies (ADVM), where the 32.40 metric serves as the target level. Adverum Biotechnologies is implementing revolutionary gene therapy that replaces regular injections for vision loss, promising high margins. The proprietary Ixo-vec vector transforms eye tissues into a drug source. Experienced management is successfully preparing the infrastructure for the final stages of trials.

ADVM: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Adverum Biotechnologies 04.07.2022 - 20.12.2025

Rincian metrik lan analitis perusahaan Adverum (ADVM)

Pambiji fundamental perusahaan:adverum.com
Produk dadi Adverum Biotechnologies Inc.

For Adverum Biotechnologies (ADVM), the change in the consensus earnings per share forecast reflects aggregated market expectations regarding the business's future profitability. This indicator measures the percentage deviation of next year's expected earnings from current values, signaling a revision of the company's financial stability. For ocular gene therapy, this metric is critically sensitive to clinical trial results and insurance reimbursement risks for treatment costs.

Pesaing utama

ALC (Alcon Corp) - Prakiraan wutah bathi kanggo taun ngarep|Bausch + Lomb Corporation (BLCO) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GKOS|Prakiraan wutah bathi kanggo taun ngarep Apellis Pharmaceuticals, Inc. (APLS)|Prakiraan wutah bathi kanggo taun ngarep BLTE (Belite Bio)|OCUL - Prakiraan wutah bathi saben saham kanggo taun ngarep|HROW - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep VRDN (Viridian Therapeutics)|LENZ (LENZ Therapeutics, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Oculis Holding AG - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep eyepointpharma.com|Prakiraan wutah bathi kanggo taun ngarep Kodiak Sciences Inc.|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aldeyra Therapeutics Inc. (ALDX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep KALA (KALA BIO)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep opusgtx.com IRD|Dinamika bathi saben saham sing diarepake ing taun ngarep OKYO|OTLK: Prakiraan wutah bathi saben saham kanggo taun ngarep|CLSD (Clearside) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|NBY: Prakiraan wutah bathi kanggo taun ngarep|Kiora Pharma (KPRX) - Prakiraan wutah bathi kanggo taun ngarep|ALIM (alimerasciences.com) - Prakiraan wutah bathi kanggo taun ngarep|eyenovia.com (EYEN) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep GHSI|OCUP (Ocuphire) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep OPT (Opthea Ltd)